Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance
| Autor: | Milad Ashrafizadeh, Hamidreza Saebfar, Mohammad Hossein Gholami, Kiavash Hushmandi, Amirhossein Zabolian, Pooria Bikarannejad, Mehrdad Hashemi, Salman Daneshi, Sepideh Mirzaei, Esmaeel Sharifi, Alan Prem Kumar, Haroon Khan, Hamid Heydari Sheikh Hossein, Massoud Vosough, Navid Rabiee, Vijay Kumar Thakur, Pooyan Makvandi, Yogendra Kumar Mishra, Franklin R. Tay, Yuzhuo Wang, Ali Zarrabi, Gorka Orive, Ebrahim Mostafavi |
|---|---|
| Přispěvatelé: | İstinye Üniversitesi, Mühendislik ve Doğa Bilimleri Fakültesi, Biyomedikal Mühendisliği Bölümü, Zarrabi, Ali |
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: |
Drug Carriers
technology industry and agriculture Drug Resistance Metal Nanoparticles Pharmaceutical Science macromolecular substances Stimuli-responsive Nanocomposites carbohydrates (lipids) Drug Delivery Systems Doxorubicin Neoplasms polycyclic compounds Humans Nanoparticles Anti-cancer Chemotherapy Graphite Gold Carbon Nanomaterials Graphene Oxide |
| Popis: | Introduction: The application of doxorubicin (DOX) in cancer therapy has been limited due to its drug resistance and poor internalization. Graphene oxide (GO) nanostructures have the capacity for DOX delivery while promoting its cytotoxicity in cancer. Areas covered: The favorable characteristics of GO nanocomposites, preparation method, and application in cancer therapy are described. Then, DOX resistance in cancer is discussed. The GO-mediated photothermal therapy and DOX delivery for cancer suppression are described. Preparation of stimuli-responsive GO nanocomposites, surface functionalization, hybrid nanoparticles, and theranostic applications are emphasized in DOX chemotherapy. Expert opinion: Graphene oxide nanoparticle-based photothermal therapy maximizes the anti-cancer activity of DOX against cancer cells. Apart from DOX delivery, GO nanomaterials are capable of loading anti-cancer agents and genetic tools to minimize drug resistance and enhance the cytolytic impact of DOX in cancer eradication. To enhance DOX accumulation in cancer cells, stimuli-responsive (redox-, light-, enzyme- and pH-sensitive) GO nanoparticles have been developed for DOX delivery. Further development of targeted delivery of DOX-loaded GO nanomaterials against cancer cells may be achieved by surface modification of polymers such as polyethylene glycol, hyaluronic acid, and chitosan. Doxorubicin-loaded GO nanoparticles have demonstrated theranostic potential for simultaneous diagnosis and therapy. Hybridization of GO with other nanocarriers such as silica and gold nanoparticles further broadens their potential anti-cancer therapy applications. 35152815 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|